Search Results - "Rasmussen, Birgitte" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

by Schreiber, Stefan, Aden, Konrad, Bernardes, Joana P., Conrad, Claudio, Tran, Florian, Höper, Hanna, Volk, Valery, Mishra, Neha, Blase, Johanna Ira, Nikolaus, Susanna, Bethge, Johannes, Kühbacher, Tanja, Röcken, Christoph, Chen, Minhu, Cottingham, Ian, Petri, Niclas, Rasmussen, Birgitte B., Lokau, Juliane, Lenk, Lennart, Garbers, Christoph, Feuerhake, Friedrich, Rose-John, Stefan, Waetzig, Georg H., Rosenstiel, Philip
Published in Gastroenterology (New York, N.Y. 1943) (01.06.2021)

Get full text

Journal Article

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution

by Jonker, Daniël M., Koch, Manuela, Larsson, Per, Ravi, Arjun, Rasmussen, Birgitte Buur, Speer, Runa, Mannaerts, Bernadette
Published in International journal of clinical pharmacology and therapeutics (01.12.2021)

Get full text

Journal Article

Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98

Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98

by VIALE, Giuseppe, REGAN, Meredith M, ÖHLSCHLEGEL, Christian, THÜRLIMANN, Beat, GELBER, Richard D, CASTIGLIONE-GERTSCH, Monica, PRICE, Karen N, GOLDHIRSCH, Aron, GUSTERSON, Barry A, COATES, Alan S, MAIORANO, Eugenio, MASTROPASQUA, Mauro G, DELL'ORTO, Patrizia, BRUUN RASMUSSEN, Birgitte, RAFFOUL, Johnny, NEVEN, Patrick, OROSZ, Zsolt, BRAYE, Stephen
Published in Journal of clinical oncology (01.09.2007)

Get full text

Journal Article

Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases

Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases

by Nikolaus, Susanna, Waetzig, Georg H., Butzin, Sven, Ziolkiewicz, Monika, Al-Massad, Natalie, Thieme, Florian, Lövgren, Ulf, Rasmussen, Birgitte B., Reinheimer, Torsten M., Seegert, Dirk, Rosenstiel, Philip, Szymczak, Silke, Schreiber, Stefan
Published in International journal of colorectal disease (01.07.2018)

Get full text

Journal Article

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

by KNOOP, Ann S, KNUDSEN, Helle, EJLERTSEN, Bent, BALSLEV, Eva, RASMUSSEN, Birgitte B, OVERGAARD, Jens, NIELSEN, Kirsten V, SCHONAU, Andreas, GUNNARSDOTTIR, Katrin, OLSEN, Karen E, MOUNDSEN, Henning
Published in Journal of clinical oncology (20.10.2005)

Get full text

Journal Article

An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)

An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)

by Laenkholm, Anne-Vibeke, Grabau, Dorthe, Møller Talman, Maj-Lis, Balslev, Eva, Bak Jylling, Anne Marie, Tabor, Tomasz Piotr, Johansen, Morten, Brügmann, Anja, Lelkaitis, Giedrius, Di Caterino, Tina, Mygind, Henrik, Poulsen, Thomas, Mertz, Henrik, Søndergaard, Gorm, Bruun Rasmussen, Birgitte
Published in Acta oncologica (01.01.2018)

Get full text

Journal Article

Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark

Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark

by Anderson, William F., Rosenberg, Philip S., Petito, Lucia, Katki, Hormuzd A., Ejlertsen, Bent, Ewertz, Marianne, Rasmussen, Birgitte B., Jensen, Maj‐Britt, Kroman, Niels
Published in International journal of cancer (01.11.2013)

Get full text

Journal Article

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

by Ejlertsen, Bent, Jensen, Maj-Britt, Rank, Fritz, Rasmussen, Birgitte B., Christiansen, Peer, Kroman, Niels, Kvistgaard, Marianne E., Overgaard, Marie, Toftdahl, Dorte B., Mouridsen, Henning T.
Published in JNCI : Journal of the National Cancer Institute (20.05.2009)

Get full text

Journal Article

Aurora kinase A as a possible marker for endocrine resistance in early estrogen receptor positive breast cancer

Aurora kinase A as a possible marker for endocrine resistance in early estrogen receptor positive breast cancer

by Lykkesfeldt, Anne E, Iversen, Benedikte R, Jensen, Maj-Britt, Ejlertsen, Bent, Giobbie-Hurder, Anita, Reiter, Birgit E, Kirkegaard, Tove, Rasmussen, Birgitte B
Published in Acta oncologica (01.01.2018)

Get full text

Journal Article

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

by Rasmussen, Birgitte B, Dr, Regan, Meredith M, ScD, Lykkesfeldt, Anne E, PhD, Dell'Orto, Patrizia, ScD, Del Curto, Barbara, ScD, Henriksen, Katrine L, MSc, Mastropasqua, Mauro G, MD, Price, Karen N, BS, Méry, Eliane, MD, Lacroix-Triki, Magali, MD, Braye, Stephen, MD, Altermatt, Hans J, MD, Gelber, Richard D, Prof, Castiglione-Gertsch, Monica, Prof, Goldhirsch, Aron, Prof, Gusterson, Barry A, Prof, Thürlimann, Beat, Prof, Coates, Alan S, Prof, Viale, Giuseppe, Prof
Published in The lancet oncology (2008)

Get full text

Journal Article

Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer

Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer

by Munch-Petersen, Helga D., Rasmussen, Birgitte B., Balslev, Eva
Published in APMIS : acta pathologica, microbiologica et immunologica Scandinavica (01.09.2014)

Get full text

Journal Article

HER2, TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients

HER2, TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients

by EJLERTSEN, Bent, JENSEN, Maj-Britt, NIELSEN, Kirsten V, BALSLEV, Eva, RASMUSSEN, Birgitte B, WILLEMOE, Gro L, HERTEL, Pernille B, KNOOP, Ann S, MOURIDSEN, Henning T, RÜNNER, Nils
Published in Journal of clinical oncology (20.02.2010)

Get full text

Journal Article

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

by Larsen, Sarah L, Yde, Christina W, Laenkholm, Anne-Vibeke, Rasmussen, Birgitte B, Duun-Henriksen, Anne Katrine, Bak, Martin, Lykkesfeldt, Anne E, Kirkegaard, Tove
Published in BMC cancer (08.04.2015)

Get full text

Journal Article

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

by Nielsen, Kirsten Vang, Ejlertsen, Bent, Müller, Sven, Møller, Susanne, Rasmussen, Birgitte B., Balslev, Eva, Lænkholm, Anne-Vibeke, Christiansen, Peer, Mouridsen, Henning T.
Published in Breast cancer research and treatment (01.06.2011)

Get full text

Journal Article

A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis

A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis

by L H Weischenfeldt, Katrine, Kirkegaard, Tove, Rasmussen, Birgitte B, Giobbie-Hurder, Anita, Jensen, Maj-Britt, Ejlertsen, Bent, Lykkesfeldt, Anne E
Published in Acta oncologica (02.09.2017)

Get full text

Journal Article

Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays

Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays

by Henriksen, Katrine L, Rasmussen, Birgitte B, Lykkesfeldt, Anne E, Møller, Susann, Ejlertsen, Bent, Mouridsen, Henning T
Published in Journal of clinical pathology (01.04.2007)

Get full text

Journal Article

In Vitro Studies Investigating the Interactions between Degarelix, a Decapeptide Gonadotropin‐Releasing Hormone Blocker, and Cytochrome P450

In Vitro Studies Investigating the Interactions between Degarelix, a Decapeptide Gonadotropin‐Releasing Hormone Blocker, and Cytochrome P450

by Sonesson, Anders, Buur Rasmussen, Birgitte
Published in Basic & clinical pharmacology & toxicology (01.09.2011)

Get full text

Journal Article

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

by Christiansen, Peer, Bjerre, Karsten, Ejlertsen, Bent, Jensen, Maj-Britt, Rasmussen, Birgitte B., Lænkholm, Anne-Vibeke, Kroman, Niels, Ewertz, Marianne, Offersen, Birgitte, Toftdahl, Dorte B., Møller, Susanne, Mouridsen, Henning T.
Published in JNCI : Journal of the National Cancer Institute (21.09.2011)

Get full text

Journal Article

Prognostic effect of estrogen receptor status across age in primary breast cancer

Prognostic effect of estrogen receptor status across age in primary breast cancer

by Bentzon, Niels, Düring, Maria, Rasmussen, Birgitte Bruun, Mouridsen, Henning, Kroman, Niels
Published in International journal of cancer (01.03.2008)

Get full text

Journal Article

One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer

One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer

by Ejlertsen, Bent, Jensen, Maj-Britt, Elversang, Johanna, Rasmussen, Birgitte B, Andersson, Michael, Andersen, Jørn, Nielsen, Dorte L, Cold, Søren, Mouridsen, Henning T
Published in European journal of cancer (1990) (01.09.2013)

Get full text

Journal Article

1
2
3
4
5
6
7
Next
[7]